Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'
- Written by PR Newswire
![]() |
- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease
- Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical trial data analysis expertise
SEOUL, South Korea, Oct. 15, 2024 /PRNewswire/ -- Neurophet, an artificial...